NO934837L - Porfycenforbindelser for fotodynamisk terapi - Google Patents

Porfycenforbindelser for fotodynamisk terapi

Info

Publication number
NO934837L
NO934837L NO934837A NO934837A NO934837L NO 934837 L NO934837 L NO 934837L NO 934837 A NO934837 A NO 934837A NO 934837 A NO934837 A NO 934837A NO 934837 L NO934837 L NO 934837L
Authority
NO
Norway
Prior art keywords
porphycene
compounds
photodynamic therapy
nhr2
aryl
Prior art date
Application number
NO934837A
Other languages
English (en)
Other versions
NO301981B1 (no
NO934837D0 (no
Inventor
Emanuel Vogel
Thomas Benninghaus
Clemens Richert
Martin Muller
Alexander Dennis Cross
Original Assignee
Cytopharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytopharm Inc filed Critical Cytopharm Inc
Publication of NO934837D0 publication Critical patent/NO934837D0/no
Publication of NO934837L publication Critical patent/NO934837L/no
Publication of NO301981B1 publication Critical patent/NO301981B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Radiation-Therapy Devices (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
NO934837A 1991-06-28 1993-12-27 Porfycen forbindelser for fotodynamisk terapi NO301981B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/723,394 US5179120A (en) 1991-06-28 1991-06-28 Porphycene compounds for photodynamic therapy
PCT/US1992/004624 WO1993000087A1 (en) 1991-06-28 1992-06-05 Porphycene compounds for photodynamic therapy

Publications (3)

Publication Number Publication Date
NO934837D0 NO934837D0 (no) 1993-12-27
NO934837L true NO934837L (no) 1994-02-24
NO301981B1 NO301981B1 (no) 1998-01-05

Family

ID=24906063

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934837A NO301981B1 (no) 1991-06-28 1993-12-27 Porfycen forbindelser for fotodynamisk terapi

Country Status (11)

Country Link
US (1) US5179120A (no)
EP (1) EP0591355B1 (no)
JP (1) JP3184218B2 (no)
AT (1) ATE190309T1 (no)
AU (1) AU664377B2 (no)
CA (1) CA2111323A1 (no)
DE (1) DE69230755T2 (no)
ES (1) ES2146213T3 (no)
FI (1) FI935878A0 (no)
NO (1) NO301981B1 (no)
WO (1) WO1993000087A1 (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876989A (en) * 1994-09-08 1999-03-02 Photocure As Transfer of molecules into the cytosol of cells

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262401A (en) * 1991-06-28 1993-11-16 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
EP0527241B1 (de) * 1991-07-15 1994-03-16 Artesan Pharma Gesellschaft mit beschränkter Haftung Verwendung der Ascorbinsäure zur Zubereitung von Arzneimitteln zur Anwendung im Genitalbereich
WO1993021842A1 (en) * 1992-04-30 1993-11-11 Quadra Logic Technologies, Inc. High-power light-emitting diodes for photodynamic therapy
US5298018A (en) * 1992-08-14 1994-03-29 Pdt Cardiovascular, Inc. Method for treating cardiovascular disease through adjunctive photodynamic therapy
DE4311627B4 (de) * 1993-04-08 2005-08-25 Robert Bosch Gmbh Kraftstoffeinspritzeinrichtung für Brennkraftmaschinen
US5616602A (en) * 1993-07-09 1997-04-01 Ciba-Geigy Corporation Topically administrable zinc phthalocyanine compositions
US5489279A (en) * 1994-03-21 1996-02-06 Dusa Pharmaceuticals, Inc. Method of applying photodynamic therapy to dermal lesion
GB9500116D0 (en) * 1995-01-05 1995-03-01 Ciba Geigy Ag Pharmaceutical compositions
US5610175A (en) * 1995-04-06 1997-03-11 Cytopharm, Inc. 9-Substituted porphycenes
US5637608A (en) * 1995-04-06 1997-06-10 Cytopharm, Inc. 9-substituted porphycenes
US5616342A (en) * 1995-04-11 1997-04-01 Pdt, Inc. Emulsioin suitable for administering a poorly water-soluble photosensitizing compound and use thereof
US5756541A (en) 1996-03-11 1998-05-26 Qlt Phototherapeutics Inc Vision through photodynamic therapy of the eye
JP2012092145A (ja) * 1996-03-11 2012-05-17 Qlt Inc 眼の光力学的治療による視力改善用組成物
GB9608484D0 (en) * 1996-04-25 1996-07-03 Glaxo Group Ltd Flourescent lamp photodynamic therapy (PDT) apparatus and method
US6416960B1 (en) 1996-08-08 2002-07-09 Prolume, Ltd. Detection and visualization of neoplastic tissues and other tissues
WO1998015271A1 (en) * 1996-10-09 1998-04-16 Emanuel Vogel 9-substituted porphycenes
US6458547B1 (en) 1996-12-12 2002-10-01 Prolume, Ltd. Apparatus and method for detecting and identifying infectious agents
US5756724A (en) * 1997-04-22 1998-05-26 Cytopharm, Inc. High-yielding ullmann reaction for the preparation of bipyrroles
US6107326A (en) * 1999-04-12 2000-08-22 Cytopharm, Inc. Porphycenes for treatment of microbial populations
US6627288B1 (en) * 2000-08-10 2003-09-30 Mitsui Chemicals, Inc. Optical recording medium and porphycene compound
AU2002222104B2 (en) 2000-11-29 2007-06-28 Pci Biotech As Photochemical internalization for virus-mediated molecule delivery into the cyosol
CZ301427B6 (cs) 2000-11-29 2010-02-24 Pci Biotech As Zpusob zavedení molekuly do cytosolu bunky
US6984734B2 (en) 2002-02-26 2006-01-10 Board Of Regents, The University Of Texas System Cyclo[n]pyrroles and methods thereto
US6723750B2 (en) 2002-03-15 2004-04-20 Allergan, Inc. Photodynamic therapy for pre-melanomas
AU2003230164B2 (en) * 2002-05-08 2008-05-01 Yeda Research And Development Co. Ltd. Sensitized online BOLD-MRI imaging method
ES2197818B1 (es) * 2002-06-11 2005-02-01 Institut Quimic De Sarria Cets 2,7,12,17 alquenil, aril y heteroaril derivados del 3,6,13,16-tetraazaporficeno, y procedimiento, compuesto intermedio y utilizaciones correspondientes.
GB2397067B (en) * 2002-12-23 2005-05-11 Destiny Pharma Ltd Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation
GB2415372A (en) 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
CN102348467B (zh) * 2009-03-16 2014-02-19 恩迪尼国际有限公司 用于光动力消毒的组合物
US8703050B2 (en) * 2009-03-16 2014-04-22 Ondine International Ltd. Composition for photodynamic disinfection
US8715920B2 (en) 2010-07-27 2014-05-06 Biovec Transfusion, Llc Composition for preserving platelets during photosensitization
ES2372854B1 (es) * 2010-07-02 2012-12-03 Institut Quimic De Sarria Cets, Fundacio Privada Derivados catiónicos de 2, 7, 12, 17-arilporficenos. procedimiento de preparación y uso como fotosensibilizadores en terapia fotodinámica antimicrobiana.
KR101933620B1 (ko) * 2012-09-18 2018-12-28 삼성전자주식회사 소포를 검출하기 위한 조성물, 키트 및 이를 이용하여 소포를 분석하는 방법
US11135316B2 (en) 2014-01-31 2021-10-05 Washington University Imaging and treatment of pathophysiologic conditions by Cerenkov radiation
US9974870B2 (en) 2014-06-09 2018-05-22 Washington University Compositions and methods for treatment and imaging using nanoparticles
CN104522058A (zh) * 2014-12-18 2015-04-22 安徽大学 一种含有藻胆蛋白的光敏杀菌剂及其制备方法及其杀菌的用途

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3592930A (en) * 1968-07-19 1971-07-13 Syntex Corp Moisture-deterioratable topical medicaments,particularly anti-inflammatory steroids,in a substantially non-aqueous fatty alcohol-propylene glycol vehicle
US4017615A (en) * 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
US3989815A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Novel N-bis-azacyclopentan-2-onyl alkanes
US3989816A (en) * 1975-06-19 1976-11-02 Nelson Research & Development Company Vehicle composition containing 1-substituted azacycloheptan-2-ones
US3991203A (en) * 1975-06-19 1976-11-09 Nelson Research & Development Company Vehicle composition containing 1-substituted azacyclopentan-2-ones
GB2026340B (en) * 1978-07-03 1982-12-22 Ash P Stabilising microvesicles
US4411893A (en) * 1981-08-14 1983-10-25 Minnesota Mining And Manufacturing Company Topical medicament preparations
US4721612A (en) * 1984-04-12 1988-01-26 The Liposome Company, Inc. Steroidal liposomes
AU603999B2 (en) * 1985-10-23 1990-12-06 Photochemical Co., Ltd. Porphyrin derivatives, and their production and use
US4861876A (en) * 1986-11-26 1989-08-29 Wayne State University Hematoporphyrin derivative and method of preparation and purification
US4837028A (en) * 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US4883790A (en) * 1987-01-20 1989-11-28 University Of British Columbia Wavelength-specific cytotoxic agents
US4957481A (en) * 1987-10-01 1990-09-18 U.S. Bioscience Photodynamic therapeutic technique
US4913907A (en) * 1988-08-15 1990-04-03 Cytopharm, Inc. Porphycene anti-cancer agents and treatment methods
US4961920A (en) * 1988-12-08 1990-10-09 Luminis Pty, Ltd. Phototherapeutic monovinyl and divinyl ether-linked dimers
NZ231658A (en) * 1988-12-12 1992-05-26 Fmc Corp Inhibitors of protoporphyrinogen oxidase and compositions for killing tumour cells
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
US5132101A (en) * 1990-05-04 1992-07-21 Cytopharm, Inc. Acetylene-cumulene porphycene compounds for photodynamic therapy
US5124449A (en) * 1990-09-20 1992-06-23 Basf Aktiengesellschaft Azaporphyrin derivatives
AU2956992A (en) * 1991-12-17 1993-07-19 Cheil Foods & Chemicals, Inc. Novel 10-hydroxy pheophytin (a)
TW235298B (no) * 1992-02-27 1994-12-01 Ciba Geigy

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5876989A (en) * 1994-09-08 1999-03-02 Photocure As Transfer of molecules into the cytosol of cells
US6680301B2 (en) 1994-09-08 2004-01-20 Photocure As Transfer of molecules into the cytosol of cells

Also Published As

Publication number Publication date
ATE190309T1 (de) 2000-03-15
CA2111323A1 (en) 1993-01-07
JP3184218B2 (ja) 2001-07-09
AU664377B2 (en) 1995-11-16
AU2187092A (en) 1993-01-25
EP0591355B1 (en) 2000-03-08
US5179120A (en) 1993-01-12
FI935878A (fi) 1993-12-27
DE69230755T2 (de) 2000-11-02
JPH06508834A (ja) 1994-10-06
EP0591355A4 (en) 1995-01-18
EP0591355A1 (en) 1994-04-13
NO301981B1 (no) 1998-01-05
NO934837D0 (no) 1993-12-27
WO1993000087A1 (en) 1993-01-07
DE69230755D1 (de) 2000-04-13
ES2146213T3 (es) 2000-08-01
FI935878A0 (fi) 1993-12-27

Similar Documents

Publication Publication Date Title
NO301981B1 (no) Porfycen forbindelser for fotodynamisk terapi
RU92016445A (ru) Применение амидов изоксазол-4-карбоновой кислоты и амидов гидроксиалкилиденциануксусной кислоты
JPS5557572A (en) Diphenylbutyllpiperazinecarboxamide and carbothioamide*its acid addition salt*its manufacture and medical composition containing it
NO861722L (no) Fremgangsmaate for fremstilling av tetrapyrrol-polyaminomonocarboxylsyrederivater.
MD921G2 (ro) Derivaţi arilpropionici, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor
RU95114740A (ru) Пептиды
FI102964B1 (fi) Terapeuttisia yhdisteitä
KR900006273A (ko) 오르토 결합 작용기를 갖는 킬란트 및 그의 착물
FI923664A0 (fi) Piperidinderivat.
EP0210351A3 (en) Use of porphyrin derivatives in the detection and treatment of tumours
HU9303009D0 (en) New 2-saccharinyl-methyl-aryl-carboxylat derivatives and pharmaceutical preparations containing said compounds
FI101597B1 (fi) Menetelmä kylmäkuivatun koostumuksen valmistamiseksi käytettäväksi potilaan valodynaamisessa hoidossa tai diagnosoinnissa
DE69426244D1 (de) Einen für Tumore cytotoxischen Faktor enthaltende pharmazeutische Zusammensetzung
ATE57927T1 (de) Dithio-verbindungen, diese enthaltende pharmazeutische praeparate und deren verwendung.
DE3883055D1 (de) Enkastine: neue glycopeptide mit enkephalinase-hemmender wirkung, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutische praeparate.
ATE64379T1 (de) Derivate von n-(methylsulfonylphenylaethyl)-2propenamiden, und deren verwendung als antibiotika.
CA2038025A1 (en) Optically active alkylenedioxybenzene derivatives and their use in therapy
FI870811A (fi) Pentapeptider med en cellvaextreglerande effekt och ett foerfarande foer framstaellning av desamma.
DE69233315D1 (de) Pharmazeutische lysin enthaltende polypeptid-zusammensetzungen und verfahren zu deren verwendung
ATE175977T1 (de) Peptide mit affinitaet zu tumoren und diese enthaltende radioaktive diagnostische und therapeutische zusammensetzungen
RU93058640A (ru) Производные порфицена, фармацевтическая композиция и способ фотодинамической терапии
ES2065242A1 (es) Derivados del acido fenilacetico, procedimiento para su obtencion y utilizacion correspondiente.
ATE36957T1 (de) N,n-diethyl-5-methyl-2h,1-benzothiopyrano-(4,3, - cd)-indazol-2-ethanamine, diese enthaltende zubereitungen und ihre verwendung.
KR970704682A (ko) 테크네튬-술폰아미드 착물, 이들의 용도, 이들을 함유하는 약제, 및 상기 착물 및 약제의 제조 방법(Technetium-Sulphonamide Complexes, Their Use, Pharmaceutical Agents Containing Them, and Process for Producing the Complexes and Agents)
SE8303400D0 (sv) Azo-bis-salicylsyra och salt derav samt deras farmaceutiska beredning och anvendning